Blueblood Ventures Key Ratios
BSE: 539637
₹11.07
₹0.52
(4.93%)
As on 29-May-2023IST
Market cap
₹3 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
158.2
P/B Ratio
-0.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -2.21 | -8.31 | -25.61 |
| EBIT | -- | -- | -1,119.41 | -378.31 | 14.01 |
| Net Profit | -- | -- | -75.82 | -34.19 | 14.89 |
| EPS | -- | -- | -75.77 | -34.15 | 14.89 |
| Book Value | -- | -- | 0.10 | -4.40 | -2.00 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -36.92 | -50.89 | -41.44 | -3.32 | -66.00 |
| Net Margin
| 4.75 | -25.08 | 0.74 | 4.52 | 8.99 |
| Return on equity
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Assets
| 0.02 | -0.12 | 0.01 | 0.03 | 0.02 |
Profitability
ROCE
0.10
Lower than Peers by 11.50
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
0.10
|
0.01
|
0.02
|
0.02
|
-0.74
|
|
Peer Median
|
11.60
|
10.11
|
13.59
|
5.01
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
12.49
|
10.06
|
11.95
|
5.53
|
--
|
ROA
0.01
Lower than Peers by 2.73
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
0.01
|
0.03
|
0.02
|
0.02
|
-0.67
|
|
Peer Median
|
2.73
|
6.32
|
8.16
|
1.69
|
--
|
EBIT Margin
-41.44
Lower than Peers by 101.77
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
-41.44
|
-3.32
|
-66.00
|
-1.36
|
-142.30
|
|
Peer Median
|
60.33
|
81.42
|
64.52
|
66.04
|
--
|
Net Margin
0.74
Lower than Peers by 54.74
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
0.74
|
4.52
|
8.99
|
3.05
|
-142.72
|
|
Peer Median
|
55.47
|
586.12
|
83.76
|
22.74
|
--
|
Cash Profit Margin
5.30
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
5.30
|
10.22
|
49.64
|
3.65
|
-141.35
|
|
Peer Median
|
--
|
0.00
|
--
|
--
|
--
|
Revenue Growth
-2.21
Lower than Peers by 20.86
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
-2.21
|
362.48
|
-82.96
|
39.76
|
-78.86
|
|
Peer Median
|
18.65
|
37.98
|
8.59
|
20.15
|
--
|
EBIT Growth
-1,119.41
Lower than Peers by 1,138.18
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
-1,119.41
|
76.71
|
-729.55
|
98.67
|
76.61
|
|
Peer Median
|
18.77
|
64.67
|
-5.20
|
14.20
|
--
|
Net Profit Growth
-75.82
Lower than Peers by 74.08
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
-75.82
|
34.07
|
-12.08
|
103.12
|
76.72
|
|
Peer Median
|
-1.74
|
63.83
|
2.11
|
28.89
|
--
|
EPS Growth
-75.77
Lower than Peers by 76.25
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
-75.77
|
34.16
|
-12.17
|
103.12
|
76.72
|
|
Peer Median
|
0.48
|
42.57
|
4.66
|
54.64
|
--
|
Book Value Growth
0.10
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
0.10
|
2.20
|
-15.28
|
0.41
|
2.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-17.25
Lower than Peers by 17.28
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
-17.25
|
-16.73
|
-16.35
|
-18.84
|
-18.77
|
|
Peer Median
|
0.02
|
0.02
|
0.03
|
0.01
|
--
|
Short term debt to equity ratio
0.99
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
0.99
|
0.04
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.70
Higher than Peers by 4.41
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
6.70
|
36.44
|
19.75
|
9.66
|
2.61
|
|
Peer Median
|
2.29
|
2.69
|
3.06
|
2.93
|
--
|
Quick Ratio
6.54
Higher than Peers by 2.62
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
6.54
|
35.19
|
18.99
|
9.10
|
2.27
|
|
Peer Median
|
3.92
|
25.81
|
21.06
|
14.18
|
--
|
Interest Coverage
1.10
Lower than Peers by 15.38
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
1.10
|
5.40
|
31.33
|
208.00
|
-300.27
|
|
Peer Median
|
16.47
|
177.44
|
210.87
|
35.31
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
--
|
--
|
--
|
152.90
|
--
|
|
Peer Median
|
17.90
|
14.11
|
6.91
|
11.95
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
--
|
--
|
--
|
-0.63
|
-0.55
|
|
Peer Median
|
1.31
|
0.47
|
0.37
|
0.46
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
0.29
|
0.45
|
0.37
|
--
|
EV/EBITDA
876.52
Higher than Peers by 848.21
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
876.52
|
2,508.68
|
1,747.16
|
4,082.36
|
-147.94
|
|
Peer Median
|
28.31
|
39.08
|
15.85
|
15.97
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Blueblood Ventures
|
--
|
--
|
--
|
3
|
3
|
|
Peer Median
|
1,801
|
858
|
471
|
399
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
